301 related articles for article (PubMed ID: 31849942)
21. The siRNA cocktail targeting interleukin 10 receptor and transforming growth factor-β receptor on dendritic cells potentiates tumour antigen-specific CD8(+) T cell immunity.
Ahn YH; Hong SO; Kim JH; Noh KH; Song KH; Lee YH; Jeon JH; Kim DW; Seo JH; Kim TW
Clin Exp Immunol; 2015 Jul; 181(1):164-78. PubMed ID: 25753156
[TBL] [Abstract][Full Text] [Related]
22. Targeted siRNA silencing of indoleamine 2, 3-dioxygenase in antigen-presenting cells using mannose-conjugated liposomes: a novel strategy for treatment of melanoma.
Chen D; Koropatnick J; Jiang N; Zheng X; Zhang X; Wang H; Yuan K; Siu KS; Shunnar A; Way C; Min WP
J Immunother; 2014; 37(2):123-34. PubMed ID: 24509175
[TBL] [Abstract][Full Text] [Related]
23. Significance of Immunosuppressive Cells as a Target for Immunotherapies in Melanoma and Non-Melanoma Skin Cancers.
Fujimura T; Aiba S
Biomolecules; 2020 Jul; 10(8):. PubMed ID: 32707850
[TBL] [Abstract][Full Text] [Related]
24. Downregulation of Stat3 in melanoma: reprogramming the immune microenvironment as an anticancer therapeutic strategy.
Emeagi PU; Maenhout S; Dang N; Heirman C; Thielemans K; Breckpot K
Gene Ther; 2013 Nov; 20(11):1085-92. PubMed ID: 23804077
[TBL] [Abstract][Full Text] [Related]
25. pim-1 proto-oncogene expression in anti-CD3-mediated T cell activation is associated with protein kinase C activation and is independent of Raf-1.
Wingett D; Long A; Kelleher D; Magnuson NS
J Immunol; 1996 Jan; 156(2):549-57. PubMed ID: 8543805
[TBL] [Abstract][Full Text] [Related]
26. Autophagy orchestrates the regulatory program of tumor-associated myeloid-derived suppressor cells.
Alissafi T; Hatzioannou A; Mintzas K; Barouni RM; Banos A; Sormendi S; Polyzos A; Xilouri M; Wielockx B; Gogas H; Verginis P
J Clin Invest; 2018 Aug; 128(9):3840-3852. PubMed ID: 29920188
[TBL] [Abstract][Full Text] [Related]
27. Oncolytic adenovirus coexpressing interleukin-12 and shVEGF restores antitumor immune function and enhances antitumor efficacy.
Ahn HM; Hong J; Yun CO
Oncotarget; 2016 Dec; 7(51):84965-84980. PubMed ID: 27821803
[TBL] [Abstract][Full Text] [Related]
28. Intratumoral administration of mRNA encoding a fusokine consisting of IFN-β and the ectodomain of the TGF-β receptor II potentiates antitumor immunity.
Van der Jeught K; Joe PT; Bialkowski L; Heirman C; Daszkiewicz L; Liechtenstein T; Escors D; Thielemans K; Breckpot K
Oncotarget; 2014 Oct; 5(20):10100-13. PubMed ID: 25338019
[TBL] [Abstract][Full Text] [Related]
29. Pim-3 promotes human pancreatic cancer growth by regulating tumor vasculogenesis.
Liu B; Wang Z; Li HY; Zhang B; Ping B; Li YY
Oncol Rep; 2014 Jun; 31(6):2625-34. PubMed ID: 24789328
[TBL] [Abstract][Full Text] [Related]
30. PIM-2 protein kinase negatively regulates T cell responses in transplantation and tumor immunity.
Daenthanasanmak A; Wu Y; Iamsawat S; Nguyen HD; Bastian D; Zhang M; Sofi MH; Chatterjee S; Hill EG; Mehrotra S; Kraft AS; Yu XZ
J Clin Invest; 2018 Jul; 128(7):2787-2801. PubMed ID: 29781812
[TBL] [Abstract][Full Text] [Related]
31. Expression of human pim family genes is selectively up-regulated by cytokines promoting T helper type 1, but not T helper type 2, cell differentiation.
Aho TL; Lund RJ; Ylikoski EK; Matikainen S; Lahesmaa R; Koskinen PJ
Immunology; 2005 Sep; 116(1):82-8. PubMed ID: 16108820
[TBL] [Abstract][Full Text] [Related]
32. Targeting PIM1-Mediated Metabolism in Myeloid Suppressor Cells to Treat Cancer.
Xin G; Chen Y; Topchyan P; Kasmani MY; Burns R; Volberding PJ; Wu X; Cohn A; Chen Y; Lin CW; Ho PC; Silverstein R; Dwinell MB; Cui W
Cancer Immunol Res; 2021 Apr; 9(4):454-469. PubMed ID: 33579728
[TBL] [Abstract][Full Text] [Related]
33. Knockdown of Pim-3 suppresses the tumorigenicity of glioblastoma by regulating cell cycle and apoptosis.
Quan J; Zhou L; Qu J
Cell Mol Biol (Noisy-le-grand); 2015 Mar; 61(1):42-50. PubMed ID: 25817345
[TBL] [Abstract][Full Text] [Related]
34. Tumor-associated antigen/IL-21-transduced dendritic cell vaccines enhance immunity and inhibit immunosuppressive cells in metastatic melanoma.
Aravindaram K; Wang PH; Yin SY; Yang NS
Gene Ther; 2014 May; 21(5):457-67. PubMed ID: 24572790
[TBL] [Abstract][Full Text] [Related]
35. Notch1 signaling in melanoma cells promoted tumor-induced immunosuppression via upregulation of TGF-β1.
Yang Z; Qi Y; Lai N; Zhang J; Chen Z; Liu M; Zhang W; Luo R; Kang S
J Exp Clin Cancer Res; 2018 Jan; 37(1):1. PubMed ID: 29301578
[TBL] [Abstract][Full Text] [Related]
36. Antitumor NK activation induced by the Toll-like receptor 3-TICAM-1 (TRIF) pathway in myeloid dendritic cells.
Akazawa T; Ebihara T; Okuno M; Okuda Y; Shingai M; Tsujimura K; Takahashi T; Ikawa M; Okabe M; Inoue N; Okamoto-Tanaka M; Ishizaki H; Miyoshi J; Matsumoto M; Seya T
Proc Natl Acad Sci U S A; 2007 Jan; 104(1):252-7. PubMed ID: 17190817
[TBL] [Abstract][Full Text] [Related]
37. NKG2D-Fc fusion protein promotes antitumor immunity through the depletion of immunosuppressive cells.
Feng PH; Lam B; Tseng SH; Kung YJ; Farmer E; Cheng MA; Hung CF
Cancer Immunol Immunother; 2020 Oct; 69(10):2147-2155. PubMed ID: 32468232
[TBL] [Abstract][Full Text] [Related]
38. 5'-triphosphate siRNA targeting HBx elicits a potent anti-HBV immune response in pAAV-HBV transfected mice.
Han Q; Hou Z; Yin C; Zhang C; Zhang J
Antiviral Res; 2019 Jan; 161():36-45. PubMed ID: 30448255
[TBL] [Abstract][Full Text] [Related]
39. [Knockdown of indoleamine 2, 3-dioxygenase 2 (IDO2)gene inhibits tumor growth and enhances immune function in mice bearing melanoma].
Liu Y; Liu H; Xiang Y; Chen X; Xu P; Min W
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 Dec; 33(12):1605-1609. PubMed ID: 29382418
[TBL] [Abstract][Full Text] [Related]
40. PIM kinases are essential for chronic lymphocytic leukemia cell survival (PIM2/3) and CXCR4-mediated microenvironmental interactions (PIM1).
Decker S; Finter J; Forde AJ; Kissel S; Schwaller J; Mack TS; Kuhn A; Gray N; Follo M; Jumaa H; Burger M; Zirlik K; Pfeifer D; Miduturu CV; Eibel H; Veelken H; Dierks C
Mol Cancer Ther; 2014 May; 13(5):1231-45. PubMed ID: 24659821
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
